Skip to main content

Table 4 Laboratory analysis

From: Repetitive vascular occlusion stimulus (RVOS) versus standard care to prevent muscle wasting in critically ill patients (ROSProx):a study protocol for a pilot randomised controlled trial

Sample

Biomarkers

Plasma and serum

Muscle anabolic marker insulin-like growth factor 1

Muscle catabolic marker Myostatin

Inflammatory cytokines interleukin (IL)-6, IL-10, tumour necrosis factor α, granulocyte–macrophage colony-stimulating factor, macrophage inflammatory protein 1, transforming growth factor β1

Angiogenic factors vascular endothelial growth factor, hypoxia inducible factor 1α

Tempus RNA tube

MicroRNAs linked with muscle atrophy such as miR-29b, miR-542-5p and miR-424-5p [108]

Peripheral blood mononuclear cells

DNA damage/repair enzymes GAD45a and APE-1

Urine

Oxidative stress-derived DNA damage marker 8-hydroxy deoxyguanosine